CellaVision Beheer

Beheer criteriumcontroles 2/4

De CEO CellaVision is Simon Ostergaard, benoemd in Mar2021, heeft een ambtstermijn van 3.67 jaar. bezit rechtstreeks 0.021% van de aandelen van het bedrijf, ter waarde SEK 1.07M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.8 jaar en 3.8 jaar.

Belangrijke informatie

Simon Ostergaard

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	3.7yrs
Eigendom CEO	0.02%
Management gemiddelde ambtstermijn	3.8yrs
Gemiddelde ambtstermijn bestuur	3.8yrs

Recente managementupdates

Recent updates

Does CellaVision (STO:CEVI) Have A Healthy Balance Sheet?

Nov 20

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 27

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 24

CellaVision AB (publ)'s (STO:CEVI) Intrinsic Value Is Potentially 46% Above Its Share Price

Apr 09

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Mar 28

CellaVision's (STO:CEVI) Dividend Will Be SEK2.25

Mar 14

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Feb 29

After Leaping 28% CellaVision AB (publ) (STO:CEVI) Shares Are Not Flying Under The Radar

Feb 16

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Feb 12

Earnings Beat: CellaVision AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 10

CellaVision's (STO:CEVI) Returns On Capital Not Reflecting Well On The Business

Dec 13

Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?

Sep 14

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Aug 22

CellaVision (STO:CEVI) Is Reinvesting At Lower Rates Of Return

Jun 17

CellaVision's (STO:CEVI) Upcoming Dividend Will Be Larger Than Last Year's

May 07

Estimating The Fair Value Of CellaVision AB (publ) (STO:CEVI)

Apr 19

CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.25

Apr 05

CellaVision (STO:CEVI) Is Paying Out A Larger Dividend Than Last Year

Mar 04

CellaVision AB (publ) (STO:CEVI) Analysts Are More Bearish Than They Used To Be

Feb 11

Is CellaVision (STO:CEVI) A Risky Investment?

Jan 13

Is CellaVision AB (publ) (STO:CEVI) Potentially Undervalued?

Dec 13

CellaVision (STO:CEVI) Seems To Use Debt Rather Sparingly

Sep 23

CellaVision (STO:CEVI) May Have Issues Allocating Its Capital

Aug 16

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Aug 02

We Ran A Stock Scan For Earnings Growth And CellaVision (STO:CEVI) Passed With Ease

Jun 27

What Is CellaVision AB (publ)'s (STO:CEVI) Share Price Doing?

May 31

CEO

Simon Ostergaard (53 yo)

3.7yrs

Tenure

Mr. Simon Ostergaard has been the Chief Executive Officer and President at CellaVision AB (publ) since March 21, 2021. He has broad experience is primarily in CellaVision's adjacent area of pathology and o...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Christer Fahraeus	Founder & Director	no data	SEK 285.00k	6.83% SEK 349.3m
Simon Ostergaard	CEO & President	3.7yrs	geen gegevens	0.021% SEK 1.1m
Magnus Blixt	Chief Financial Officer	11.5yrs	geen gegevens	0.017% SEK 858.0k
Adele Horn	Corporate Communications & Investor Relations Manager	no data	geen gegevens	geen gegevens
Peter Wilson	Vice President of Global Marketing	no data	geen gegevens	0.013% SEK 643.6k
Urban Strindlov	Vice President of Global Sales	2.8yrs	geen gegevens	geen gegevens
Nina Wallander	Vice President of Human Resources	3.8yrs	geen gegevens	geen gegevens

3.8yrs

Gemiddelde duur

57.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CEVI wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Christer Fahraeus	Founder & Director	30.8yrs	SEK 285.00k	6.83% SEK 349.3m
Mikael Worning	Independent Chairman of the Board	4.8yrs	SEK 800.00k	0.0099% SEK 506.0k
Stefan Wolf	Independent Director	6.5yrs	SEK 260.00k	geen gegevens
Ann-Charlotte Jarleryd	Independent Director	2.5yrs	SEK 360.00k	geen gegevens
Kent Strahlen	Independent Employee Representative Director	2.8yrs	geen gegevens	0.0042% SEK 214.4k
Louise Armstrong-Denby	Independent Director	1.5yrs	SEK 130.00k	geen gegevens

3.8yrs

Gemiddelde duur

58.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CEVI wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).

CellaVision Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

CellaVision AB (publ), Annual General Meeting, May 06, 2025

Founder & Director recently sold kr27m worth of stock

Founder & Director recently bought kr63k worth of stock

CellaVision AB (publ) Announces the Appointment of Emil Hjalmarsson as Chairman of the Nomination Committee

Recent updates

Does CellaVision (STO:CEVI) Have A Healthy Balance Sheet?

CellaVision AB (publ), Annual General Meeting, May 06, 2025

Now 23% undervalued after recent price drop

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Now 21% undervalued

Now 23% undervalued

Founder & Director recently sold kr27m worth of stock

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Now 21% undervalued

Is CellaVision (STO:CEVI) A Risky Investment?

Does CellaVision (STO:CEVI) Deserve A Spot On Your Watchlist?

Investor sentiment improves as stock rises 15%

Upcoming dividend of kr2.25 per share

First quarter 2024 earnings released: EPS: kr1.26 (vs kr0.81 in 1Q 2023)

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CellaVision (STO:CEVI) Is Due To Pay A Dividend Of SEK2.25

CellaVision AB (publ)'s (STO:CEVI) Intrinsic Value Is Potentially 46% Above Its Share Price

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

CellaVision's (STO:CEVI) Dividend Will Be SEK2.25

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Now 22% undervalued

Now 21% undervalued

After Leaping 28% CellaVision AB (publ) (STO:CEVI) Shares Are Not Flying Under The Radar

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Earnings Beat: CellaVision AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Dividend of kr2.25 announced

Price target increased by 21% to kr232

Consensus EPS estimates fall by 13%

Investor sentiment improves as stock rises 30%

Now 21% undervalued

CellaVision's (STO:CEVI) Returns On Capital Not Reflecting Well On The Business

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 18%

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CellaVision AB (publ) to Report Nine Months, 2024 Results on Oct 24, 2024

CellaVision AB (publ) to Report Q3, 2023 Results on Oct 25, 2023

Price target decreased by 8.0% to kr203

Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?

Now 21% undervalued after recent price drop

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Price target increased by 8.6% to kr220

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 17%

CellaVision AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

Investor sentiment deteriorates as stock falls 17%

CellaVision (STO:CEVI) Is Reinvesting At Lower Rates Of Return

CellaVision's (STO:CEVI) Upcoming Dividend Will Be Larger Than Last Year's

Cellavision AB (Publ) Approves Dividend, Payable on May 12, 2023

Upcoming dividend of kr2.25 per share at 1.3% yield

Consensus EPS estimates increase by 13%

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 11%

Estimating The Fair Value Of CellaVision AB (publ) (STO:CEVI)

Price target decreased by 11% to kr223

Full year 2022 earnings: EPS and revenues miss analyst expectations

CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.25

Now 22% undervalued after recent price drop

CellaVision (STO:CEVI) Is Paying Out A Larger Dividend Than Last Year

Now 21% undervalued after recent price drop

Founder & Director recently bought kr63k worth of stock

CellaVision AB (publ) (STO:CEVI) Analysts Are More Bearish Than They Used To Be

Full year 2022 earnings released: EPS: kr4.96 (vs kr5.26 in FY 2021)

Cellavision AB (Publ) Proposes Dividend for 2022

Now 23% undervalued

Investor sentiment improves as stock rises 15%

Is CellaVision (STO:CEVI) A Risky Investment?

Now 21% undervalued after recent price drop

Investor sentiment improved over the past week

Is CellaVision AB (publ) (STO:CEVI) Potentially Undervalued?